Comex Reports Latvia 29 - organic chemicals 2937 - hormones

Deploy a report





Chart - Latvia - Imports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Chart - Latvia - Imports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Table - Latvia - Imports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024 2025
India 26.910 46.374 21.322 55.622 154.386 33.974
Turkey 317 120.258 65.615
Germany 7.344 11.288 8.803 18.048 122.169 3.238
Lithuania 1.318 75.541 8.822
Netherlands 3.079 15.656 507 28.862
China 2.798 9.646 5.987 5.635 5.170 2.178
Poland 5.683 7.708 13.427 2.894
Canada 5.905 10.794 12.275
United States 3.993 580 581 3.179 3.033
South Korea 8.939
Others 9.224 10.676 542 8.005 2.555 3.422
Total 50,270 91,470 68,073 327,646 365,151 71,675

Chart - Latvia - Imports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Chart - Latvia - Imports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Table - Latvia - Imports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Date
Export Countries
 10 - 2024 11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025
India 113 33.862
Netherlands 296 211 28.862
Germany 8.134 1.894 653 1.357 1.798 84
China 4.102 677 1.501
France 512 538 1.078
United Kingdom 604 430
Estonia 95 54 150 477 99
Lithuania 303
Spain 144
Austria 46
Total 12,532 2,646 1,221 2,761 66,106 2,808

Chart - Latvia - Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Chart - Latvia - Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Table - Latvia - Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Date
Import Countries
 2020 2021 2022 2023 2024 2025
Poland 91.917 146.551 139.142 21.325 144.709 38.546
Thailand 166.059 118.149 131.892 92.628
Germany 104.693 164.328 46.267 156.332 25.764 1.742
Egypt 39.273 58.192 116.393 12.437 96.295 28.566
Belgium 59.273 60.880 63.477 61.802 39.664 64.942
United States 18.913 57.805 55.903 99.972 74.955 16.915
Slovakia 66.860 117.436 66.253 68.553
Netherlands 95.952 45.872 14.853 31.188 69.263 20.124
Russia 81.205 28.832 335 4.501 149.767
China 22.869 9.753 43.007 73.890 82.360
Others 413.030 414.833 294.964 395.521 386.305 52.443
Total 1,093,184 1,172,055 891,778 988,861 1,227,963 291,831

Chart - Latvia - Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Chart - Latvia - Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Table - Latvia - Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Date
Import Countries
 10 - 2024 11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025
Slovakia 66.253 68.553
Poland 61.232 255 1.244 37.205 97
Thailand 92.628
Belgium 18.912 14.778 29.717 20.447
Netherlands 38.978 12.503 7.621
China 51.379
United States 18.113 16.915
Egypt 9.513 19.053
Germany 18.938 102 584 71 1.611 59
South Korea 19.263
Others 35.251 25.206 33.394 16.457 33.345 2.641
Total 265,940 162,459 52,091 32,550 192,447 66,833

Chart - Latvia - Imports - Evolution / Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Chart - Latvia - Imports - Evolution / Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Table - Latvia - Imports - Evolution / Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024 2025
Importaciones
India 26.910 46.374 21.322 55.622 154.386 33.974
Turkey 317 120.258 65.615
Germany 7.344 11.288 8.803 18.048 122.169 3.238
Lithuania 1.318 75.541 8.822
Netherlands 3.079 15.656 507 28.862
China 2.798 9.646 5.987 5.635 5.170 2.178
Poland 5.683 7.708 13.427 2.894
Canada 5.905 10.794 12.275
United States 3.993 580 581 3.179 3.033
South Korea 8.939
Others 9.224 10.676 542 8.005 2.555 3.422
Total 50,270 91,470 68,073 327,646 365,151 71,675

Date
Import Countries
 2020 2021 2022 2023 2024 2025
Exportaciones
Poland 91.917 146.551 139.142 21.325 144.709 38.546
Thailand 166.059 118.149 131.892 92.628
Germany 104.693 164.328 46.267 156.332 25.764 1.742
Egypt 39.273 58.192 116.393 12.437 96.295 28.566
Belgium 59.273 60.880 63.477 61.802 39.664 64.942
United States 18.913 57.805 55.903 99.972 74.955 16.915
Slovakia 66.860 117.436 66.253 68.553
Netherlands 95.952 45.872 14.853 31.188 69.263 20.124
Russia 81.205 28.832 335 4.501 149.767
China 22.869 9.753 43.007 73.890 82.360
Others 413.030 414.833 294.964 395.521 386.305 52.443
Total 1,093,184 1,172,055 891,778 988,861 1,227,963 291,831

Chart - Latvia - Imports - Evolution / Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Chart - Latvia - Imports - Evolution / Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Table - Latvia - Imports - Evolution / Exports - Evolution - NCE: hormones - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - Monthly FOB USD

Date
Export Countries
 10 - 2024 11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025
Importaciones
India 113 33.862
Netherlands 296 211 28.862
Germany 8.134 1.894 653 1.357 1.798 84
China 4.102 677 1.501
France 512 538 1.078
United Kingdom 604 430
Estonia 95 54 150 477 99
Lithuania 303
Spain 144
Austria 46
Total 12,532 2,646 1,221 2,761 66,106 2,808

Date
Import Countries
 10 - 2024 11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025
Exportaciones
Slovakia 66.253 68.553
Poland 61.232 255 1.244 37.205 97
Thailand 92.628
Belgium 18.912 14.778 29.717 20.447
Netherlands 38.978 12.503 7.621
China 51.379
United States 18.113 16.915
Egypt 9.513 19.053
Germany 18.938 102 584 71 1.611 59
South Korea 19.263
Others 35.251 25.206 33.394 16.457 33.345 2.641
Total 265,940 162,459 52,091 32,550 192,447 66,833